HOME >> BIOLOGY >> NEWS
A candidate gene for familial idiopathic pulmonary fibrosis identified

ELMOD2-gene is a prime candidate gene for familial idiopathic pulmonary fibrosis, suggests the recent study published by the researchers at the University and University Hospital of Helsinki, Finland.

Idiopathic pulmonary fibrosis (IPF) is a chronic, late-onset disease of lung parenchyma with unknown etiology. IPF has been treated with corticosteroids and immunosuppressive agents, but the prognosis and the response to treatment have remained poor, and the estimated time of survival from the diagnosis is less than 3 years. The pathogenesis and etiology of IPF are unknown, but the reports of multiple affected family members in the same family support the influence of genetic factors.

In their previous studies researchers at the University of Helsinki and the University Hospital of Helsinki observed that the prevalence of idiopathic pulmonary fibrosis distributed unevenly in Finland. The prevalence was two times higher in eastern and southern Savo (45/100 000 inhabitants) compared to the prevalence in Finland (16-18/100 000).

The researchers identified multiplex families with IPF and noticed that familial IPF patients clustered within Savo and Carelia, the same areas with the high prevalence, suggesting that they most likely share a common disease-causing allele introduced by a common ancestor.

They performed a genome-wide scan with six multiplex families. Three regions on chromosomes 3, 4, and 13 obtained NPL scores of 1.7, 1.7, and 1.6, respectively, and on chromosomes 9 and 12 possible shared haplotypes were seen. These five loci were fine mapped with 63 markers in an extended data set.

After fine mapping the researchers did not detect the linkage to the loci on chromosomes 3, 9, 12, and 13. On chromosome 4q31.1 the NPL score increased to 2.1, and one third of the affected families (8/24) shared a 110 kb haplotype, while none of the unaffected family members carried it. The susceptibility haplotype was carried in 34
'"/>

Contact: Dr. Ulla Hodgson
ulla.hodgson@hus.fi
35-850-427-0959
University of Helsinki
28-Jun-2006


Page: 1 2

Related biology news :

1. Scientists identify a candidate gene for osteoporosis
2. Study shows gene candidates for predisposition
3. Plexxikon advances first oncology development candidate
4. Astronomer announces shortlist of stellar candidates for habitable worlds
5. U of S researchers develop new vaccine candidate against hepatitis C
6. GlaxoSmithKlines rotavirus vaccine candidate shown effective
7. New results show the RTS,S malaria vaccine candidate protects children for at least 18 months
8. A genome wide search for genes underlying anxiety disorders turned up unexpected candidates
9. Study reveals candidate targets for anti-retroviral therapeutics
10. Automated imaging screen reveals promising drug candidates
11. SERPINE2 identified as novel candidate gene for COPD, especially with smoking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/27/2018)... (PRWEB) , ... December 27, 2018 , ... ... 60 cervical discs for implantation at its new Boston facility, and is now ... have additional inventory to immediately expand market share against inferior ball and socket ...
(Date:12/20/2018)... PARK, N.C. (PRWEB) , ... December 20, 2018 ... ... been enhanced through upgraded processes and the completion of a new usability/observation room. ... with the goal of ensuring medical devices and drug delivery devices/combination products are ...
(Date:12/18/2018)... PHOENIX (PRWEB) , ... December 18, 2018 , ... ... Cell, has effectively incorporated artificial intelligence into client marketing. The technology has been ... six years, R3 Stem Cell has been working with clients nationwide on patient ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... January 07, 2019 , ... Today ... Noninvasix. This represents the second investment AngelMD has made into Noninvasix in the ... is developing a patient monitor to directly, accurately, and noninvasively measure brain oxygenation ...
(Date:1/4/2019)... ... January 02, 2019 , ... ... and cancer cells in blood, has been named as a partner in Medigen ... company developing cell therapies for cancer treatment, will use CellMax Life’s circulating tumor ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
(Date:12/13/2018)... , ... December 12, 2018 , ... ... life science software solutions, announces the Limfinity® ML (Machine Learning) addition for its ... machine learning models within Limfinity® solutions. In the module, trained models make predictions ...
Breaking Biology Technology:
Cached News: